Insider Buying: Aditxt (NASDAQ:ADTX) Major Shareholder Purchases 843,622 Shares of Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt bought 843,622 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was bought at an average cost of $0.08 per share, with a total value of $67,489.76. Following the completion of the purchase, the insider owned 505,302 shares of the company’s stock, valued at approximately $40,424.16. The trade was a -249.36% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The stock was sold at an average price of $0.06, for a total transaction of $44,127.72.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The shares were acquired at an average price of $8.91 per share, with a total value of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Trading Down 19.6%

Shares of ADTX traded down $0.01 on Monday, reaching $0.05. 34,601,770 shares of the company’s stock were exchanged, compared to its average volume of 2,810,720. The business has a 50 day moving average price of $7.80 and a two-hundred day moving average price of $170.33. Aditxt, Inc. has a 12 month low of $0.05 and a 12 month high of $53,451.08. The stock has a market capitalization of $40,718.40, a P/E ratio of 0.00 and a beta of 0.84.

Aditxt (NASDAQ:ADTX) last released its earnings results on Tuesday, March 31st. The company reported $315,563.31 EPS for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Wall Street Zen raised Aditxt to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research report on Monday, April 20th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.